Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel N-N axis chiral ligand synthesis via organocatalysis. High enantioselectivity for pharma intermediates. Cost-effective scalable route for complex molecule manufacturing.
Patent CN116444400B reveals a novel Pd-catalyzed synthesis for high-purity chiral amines. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel nickel-catalyzed route for tetralone skeletons offering high ee values and cost-effective manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed synthesis offers high enantioselectivity. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN114057717B reveals novel ligand synthesis enhancing enantioselectivity. Delivers substantial cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Discover novel axial chiral oxindole-derived styrene phosphine catalysts from patent CN111777637B. Enables asymmetric cyclization with mild conditions and scalable synthesis for fine chemical manufacturing.
Patent CN116041393B reveals a novel N-N axis chiral bis-indole phosphine ligand offering superior stereoselectivity for asymmetric allylation and cost-effective pharmaceutical intermediate manufacturing.
Patent CN108864189A reveals a novel one-pot synthesis for sulfinamide chiral ligands, enabling cost-effective production of high-purity pharmaceutical intermediates via asymmetric Heck reactions.
Patent CN112920053A reveals a safer, high-yield route for chiral amines used in asthma and cancer drugs, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN108409615B reveals a scalable method for enantiopure tert-butyl sulfinamide. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with this novel route.
Patent CN102659494A discloses a novel organocatalytic route for 3,3-disubstituted-2-oxindoles, offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Discover the novel asymmetric preparation of tamsulosin hydrochloride via ferrocenyl auxiliaries. A cost-effective, high-purity pharmaceutical intermediate solution.
Advanced organocatalytic route for chiral indoxazinone compounds offering high enantioselectivity and scalable manufacturing for pharmaceutical intermediates.
Discover the novel Sc(OTf)3-catalyzed synthesis of indole-derived piperidines. A cost-effective, high-yield route for anticancer pharmaceutical intermediates with superior diastereoselectivity.
Patent CN110452150B reveals a novel organocatalytic route for high-purity axial chiral indole-naphthalene synthesis, offering significant cost reduction and supply chain reliability.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high cytotoxicity, offering cost-effective API intermediate manufacturing solutions.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity and cost-effective synthesis for asymmetric catalysis.
Novel oxindole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions for fine chemical manufacturing.
Patent CN108794420B discloses a novel bisoxazoline ligand synthesis from cheap bisphenols, offering significant cost reduction and scalable production for asymmetric catalysis.